There is little data on pediatric use of IBS treatments, but a small study of 59 patients found the VSL #3 probiotic might improve quality of life in children with the disease. The study, presented at last week's ACG meeting, demonstrated the probiotic was safe and that it resulted in a significant improvement in symptoms over a placebo.

Related Summaries